Detailed Liver Function Test (LFT) at Ayzal Lab

Detailed Liver Function Test (LFT) at Ayzal Lab

A Detailed Liver Function Test (LFT) is a comprehensive panel of blood tests designed to evaluate the clinical status of the hepatobiliary system. Performed at Ayzal Lab in Lahore, Pakistan, this diagnostic profile measures specific proteins, enzymes, and bilirubin levels in the bloodstream. The liver is a vital organ responsible for detoxification, protein synthesis, metabolic regulation, and the production of biochemicals necessary for digestion. When hepatic cells are damaged or biliary flow is obstructed, the concentration of these biomarkers changes predictably, allowing pathologists and clinicians to identify underlying pathologies.

The Detailed Liver Function Test at Ayzal Lab utilizes advanced automated biochemistry analyzers to ensure precise quantification of hepatic enzymes and proteins. By assessing parameters such as Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST), Alkaline Phosphatase (ALP), Gamma-Glutamyl Transferase (GGT), Total Bilirubin, Direct Bilirubin, Indirect Bilirubin, Total Protein, Albumin, and the Albumin-to-Globulin (A/G) ratio, this panel provides a holistic view of liver health. It serves as an essential tool for diagnosing hepatic diseases, monitoring treatment efficacy, and screening patients who are taking potentially hepatotoxic medications.

Understanding the clinical importance of each parameter is key to interpreting the LFT panel. ALT and AST are intracellular enzymes; their elevation in the serum directly indicates hepatocellular injury. ALP and GGT are markers of the biliary system, and elevated levels often point to cholestasis or bile duct obstruction. Bilirubin measurements help differentiate between pre-hepatic, intra-hepatic, and post-hepatic jaundice. Meanwhile, synthetic function is assessed through serum albumin and total protein levels, which reflect the liver’s long-term capacity to manufacture essential blood proteins. This comprehensive diagnostic value makes the Detailed LFT an indispensable component of routine and specialized medical evaluations.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the highest level of diagnostic accuracy and prevent external factors from altering your blood chemistry, patients must adhere to the following preparation guidelines prior to undergoing a Detailed Liver Function Test (LFT) at Ayzal Lab:

• Fasting Requirements: Patients are required to fast for 8 to 12 hours before the blood draw. During this fasting period, only plain water is permitted. Avoid juices, tea, coffee, sodas, and food, as these can artificially alter blood glucose, lipid levels, and certain liver enzymes.
• Medication Disclosure: Inform the healthcare provider and the laboratory staff at Ayzal Lab about all prescription medications, over-the-counter drugs, herbal remedies, and dietary supplements you are currently taking. Certain medications, such as statins, antibiotics, and acetaminophen, can influence liver enzyme levels. Do not stop taking prescribed medications unless explicitly instructed by your physician.
• Alcohol Avoidance: Abstain from consuming alcohol for at least 24 to 48 hours before the test. Alcohol consumption can cause transient elevations in liver enzymes, particularly Gamma-Glutamyl Transferase (GGT) and Alanine Aminotransferase (ALT), leading to misleading diagnostic results.
• Avoid Strenuous Exercise: Refrain from intense physical activity or heavy exercise the day before the test, as extreme exertion can temporarily elevate Aspartate Aminotransferase (AST) levels due to muscle metabolism.
• Hydration: Drink an adequate amount of water during the fasting period. Proper hydration ensures that veins are easily accessible for venipuncture, minimizing patient discomfort during sample collection.

During the Procedure

The Detailed Liver Function Test is a straightforward laboratory procedure involving a standard venipuncture. Upon arriving at Ayzal Lab, you will be greeted by a professional phlebotomist who will guide you through the process to ensure a comfortable and safe experience:

• Patient Identification and Verification: The phlebotomist will verify your identity, confirm your test details, and ask if you have followed the necessary fasting guidelines.
• Positioning: You will be asked to sit comfortably in a specialized blood-drawing chair. You should extend your arm, resting it on the armrest with the palm facing upward.
• Site Selection and Preparation: The phlebotomist will inspect your antecubital fossa (the crease of your elbow) to locate a suitable, prominent vein. Once selected, the area will be thoroughly cleansed with an antiseptic alcohol swab to eliminate surface bacteria and prevent infection.
• Tourniquet Application: A soft elastic tourniquet will be tied around your upper arm. This temporarily restricts blood flow, causing the veins to swell and become more visible and accessible. You may be asked to clench your fist to further engorge the vein.
• Venipuncture: A sterile, single-use needle attached to a vacuum collection tube is gently inserted into the selected vein. You may feel a brief, mild pinch or stinging sensation as the needle enters the skin.
• Sample Collection: Blood will flow naturally into the collection tube. For a Detailed LFT, a gold-top (serum separator) or red-top tube is typically used. Once the required volume of blood is collected, the tourniquet is released, and the needle is smoothly withdrawn.
• Post-Puncture Care: The phlebotomist will immediately apply a sterile cotton ball or gauze pad to the puncture site, instructing you to apply gentle pressure for a few minutes to stop any minor bleeding. A small adhesive bandage will then be placed over the site.
• Duration and Safety: The entire blood collection process takes less than five minutes. All equipment used at Ayzal Lab is sterile, disposable, and strictly single-use, adhering to international biosafety standards to eliminate any risk of cross-contamination.

When is a Detailed Liver Function Test (LFT) Performed?

Screening for Hepatobiliary Diseases

Physicians frequently order a Detailed Liver Function Test as a screening tool during routine physical examinations or wellness checkups, even in asymptomatic patients. Because many chronic liver conditions, such as non-alcoholic fatty liver disease (NAFLD) and early-stage chronic hepatitis, progress silently without obvious symptoms, routine LFT screening helps detect subclinical hepatic inflammation or dysfunction early, allowing for timely lifestyle or medical interventions.

Evaluating Symptoms of Liver Dysfunction

When a patient presents with clinical signs suggestive of hepatobiliary pathology, a Detailed LFT is immediately indicated. Key symptoms that prompt clinicians to request this panel include jaundice (yellowing of the skin and sclera), unexplained dark urine, pale or clay-colored stools, persistent abdominal pain (particularly in the right upper quadrant), chronic fatigue, unexplained nausea, vomiting, and pruritus (generalized itchy skin).

Monitoring Patients on Hepatotoxic Medications

Many commonly prescribed medications, including cholesterol-lowering statins, certain antibiotics, anti-tuberculosis drugs, antiepileptics, and long-term nonsteroidal anti-inflammatory drugs (NSAIDs), carry a risk of drug-induced liver injury (DILI). Clinicians order baseline LFTs before initiating these therapies and schedule periodic follow-up tests to monitor liver enzyme levels, ensuring early detection of drug-induced hepatic stress before severe damage occurs.

Assessing Chronic Alcohol Consumption and Substance Use

Chronic alcohol consumption is a primary cause of liver disease, ranging from fatty liver to alcoholic hepatitis and cirrhosis. Physicians utilize the Detailed LFT panel—specifically looking at the ratio of AST to ALT (where AST is often more than twice the level of ALT in alcoholic liver disease) and elevated GGT levels—to assess the impact of alcohol on hepatic tissue, monitor recovery during abstinence, and guide rehabilitation protocols.

Managing and Monitoring Known Liver Conditions

For patients already diagnosed with chronic liver conditions, such as chronic Hepatitis B or C, autoimmune hepatitis, hemochromatosis, Wilson’s disease, or liver cirrhosis, the Detailed LFT is performed at regular intervals. These serial measurements allow gastroenterologists and hepatologists to assess the progression of the disease, evaluate the patient’s response to antiviral or immunosuppressive therapies, and detect complications like hepatic insufficiency.

What Does a Detailed Liver Function Test (LFT) Detect?

The Detailed Liver Function Test at Ayzal Lab is highly sensitive and capable of detecting a wide array of pathological changes, functional impairments, and structural abnormalities within the hepatobiliary system. By analyzing the specific patterns of enzyme elevations and protein deficiencies, the test can identify:

• Acute Hepatocellular Injury: Significant elevations in ALT and AST indicate acute damage to hepatocytes, commonly caused by acute viral hepatitis (A, B, C, D, or E), drug toxicities, or ischemic hepatitis (shock liver).
• Chronic Hepatocellular Inflammation: Mild to moderate elevations in ALT and AST persisting over months point toward chronic liver inflammation, often associated with chronic Hepatitis B or C, non-alcoholic steatohepatitis (NASH), or autoimmune hepatitis.
• Cholestasis and Biliary Obstruction: Marked elevations in Alkaline Phosphatase (ALP) and Gamma-Glutamyl Transferase (GGT) indicate impaired bile flow. This can be caused by extrahepatic obstructions (such as gallstones, biliary strictures, or pancreatic tumors) or intrahepatic cholestasis (such as primary biliary cholangitis or drug-induced cholestasis).
• Hyperbilirubinemia: Elevated total bilirubin levels indicate jaundice. By analyzing direct (conjugated) and indirect (unconjugated) bilirubin fractions, the test helps differentiate between hemolytic disorders (pre-hepatic), hepatocellular damage (hepatic), and biliary tract obstruction (post-hepatic).
• Impaired Synthetic Capacity: Decreased levels of serum albumin and total protein indicate that the liver’s synthetic function is compromised. This is a hallmark of advanced chronic liver disease, such as decompensated liver cirrhosis, but can also occur in severe malnutrition or nephrotic syndrome.
• Alcohol-Induced Liver Injury: An AST level that is significantly higher than the ALT level (often an AST/ALT ratio greater than 2:1), accompanied by an isolated elevation in GGT, strongly suggests alcoholic liver disease.
• Fatty Liver Disease: Mild, chronic elevations of ALT and AST, with or without mild ALP elevation, in patients with metabolic risk factors (obesity, diabetes, dyslipidemia) often indicate non-alcoholic fatty liver disease (NAFLD).
• Hepatic Encephalopathy Risk: While not a direct measure of ammonia, severe derangements in LFT parameters combined with low albumin levels indicate advanced liver failure, which increases the clinical risk of hepatic encephalopathy.
• Cirrhosis Progression: Progressive declines in albumin levels, inversion of the normal Albumin-to-Globulin (A/G) ratio, and worsening bilirubin levels help clinicians track the severity and staging of liver cirrhosis.
• Systemic Infections and Infiltrative Disorders: Elevated ALP with normal or near-normal bilirubin and transaminases can sometimes indicate infiltrative liver diseases, such as sarcoidosis, tuberculosis, amyloidosis, or metastatic liver cancer.

Turnaround Time and Report Access at Ayzal Lab

At Ayzal Lab, we understand that timely diagnostic results are crucial for effective clinical decision-making and patient peace of mind. The Detailed Liver Function Test (LFT) is processed using state-of-the-art, fully automated clinical chemistry analyzers that ensure both rapid processing and high analytical precision. Typically, the routine turnaround time for a Detailed LFT report at Ayzal Lab is within 8 to 12 hours from the time of sample collection.

Once the analysis is complete, the results undergo a rigorous multi-level quality control review by our qualified laboratory technologists and consultant pathologists to ensure absolute accuracy. Patients and referring physicians are notified via SMS as soon as the report is finalized. Reports can be accessed and downloaded online through the official Ayzal Lab patient portal, or collected in person as a printed document from our main facility or designated collection centers in Lahore.

Detailed Liver Function Test (LFT) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Alanine Aminotransferase (ALT)	Low levels (typically < 45 U/L)	Elevated in acute/chronic hepatitis, fatty liver, drug-induced liver injury, and hepatic ischemia.
Aspartate Aminotransferase (AST)	Low levels (typically < 40 U/L)	Elevated in liver injury, myocardial infarction, muscle trauma, and alcoholic liver disease (AST/ALT > 2).
Alkaline Phosphatase (ALP)	Moderate levels (typically 40–130 U/L)	Markedly elevated in biliary obstruction, cholestasis, bone disorders, and infiltrative liver diseases.
Gamma-Glutamyl Transferase (GGT)	Low levels (typically < 60 U/L)	Elevated in cholestasis, biliary tract disease, alcohol abuse, and hepatotoxic drug use.
Total Bilirubin	0.2 – 1.2 mg/dL	Elevated (jaundice) due to hemolysis, hepatocellular damage, or biliary tract obstruction.
Direct (Conjugated) Bilirubin	0.0 – 0.3 mg/dL	Elevated in biliary obstruction, hepatitis, cirrhosis, and congenital excretion disorders (e.g., Dubin-Johnson).
Serum Albumin	3.5 – 5.0 g/dL	Decreased in chronic liver disease (cirrhosis), malnutrition, kidney disease, and chronic inflammation.
Total Protein	6.0 – 8.3 g/dL	Decreased in liver failure and malabsorption; elevated in chronic infections, dehydration, and multiple myeloma.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Ayzal Lab for Detailed Liver Function Test (LFT)?

• Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified pathologists, clinical biochemists, and skilled phlebotomists dedicated to maintaining the highest standards of diagnostic medicine.
• Patient-Focused Care: At Ayzal Lab, we prioritize patient comfort, safety, and confidentiality, ensuring a seamless and stress-free diagnostic experience from registration to report delivery.
• Quality Diagnostic Services: We implement stringent internal quality control protocols and participate in external quality assurance programs to guarantee the clinical accuracy of every test result.
• Professional Reporting: Our reports are detailed, structured, and easy for both patients and clinicians to interpret, featuring clear reference ranges and pathological highlights.
• Modern Diagnostic Approach: Ayzal Lab utilizes advanced, fully automated biochemistry analyzers and modern laboratory information management systems (LIMS) to minimize human error and optimize efficiency.
• Comfortable Environment: Our collection centers are designed to provide a clean, hygienic, and welcoming atmosphere, helping patients feel relaxed during their visits.
• Convenient Location: Located accessibly within Lahore, Ayzal Lab offers easy access for patients seeking reliable diagnostic services across the city.
• Commitment to Accurate Diagnosis: We are dedicated to providing timely, precise, and evidence-based diagnostic insights that empower physicians to make informed clinical decisions and improve patient outcomes.